http://www.beckershospitalreview.com/hospital-transactions-and-valuation/healthcare-s-40b-day-5-things-to-know-about-thursday-s-mega-mergers.html

Some of the deal activity among medical device makers and pharmaceutical companies can be explained by the belief that gaining scale and becoming a leading provider is essential for effectively negotiating business with hospitals and insurers, according to The New York Times. Some of the impetus to consolidate can also be explained by the desire to acquire emerging product lines and biotech firms to supplement the declining sales of older products.